9188 related articles for article (PubMed ID: 14720384)
1. [Study progress of p73 gene in digestive system carcinoma].
Xin T; Fang LP
Ai Zheng; 2004 Jan; 23(1):95-8. PubMed ID: 14720384
[TBL] [Abstract][Full Text] [Related]
2. No associations of p73 G4C14-to-A4T14 at exon 2 and p53 Arg72Pro polymorphisms with the risk of digestive tract cancers in Japanese.
Hamajima N; Matsuo K; Suzuki T; Nakamura T; Matsuura A; Hatooka S; Shinoda M; Kodera Y; Yamamura Y; Hirai T; Kato T; Tajima K
Cancer Lett; 2002 Jul; 181(1):81-5. PubMed ID: 12430182
[TBL] [Abstract][Full Text] [Related]
3. Infrequent somatic mutations of the p73 gene in various human cancers.
Han S; Semba S; Abe T; Makino N; Furukawa T; Fukushige S; Takahashi H; Sakurada A; Sato M; Shiiba K; Matsuno S; Nimura Y; Nakagawara A; Horii A
Eur J Surg Oncol; 1999 Apr; 25(2):194-8. PubMed ID: 10218465
[TBL] [Abstract][Full Text] [Related]
4. Genetic alternations of p73 are infrequent but may occur in early stage hepatocellular carcinoma.
Peng CY; Tsai SL; Yeh CT; Hung SP; Chen MF; Chen TC; Chu CM; Liaw YF
Anticancer Res; 2000; 20(3A):1487-92. PubMed ID: 10928060
[TBL] [Abstract][Full Text] [Related]
5. Mutation analysis of P73 and TP53 in Merkel cell carcinoma.
Van Gele M; Kaghad M; Leonard JH; Van Roy N; Naeyaert JM; Geerts ML; Van Belle S; Cocquyt V; Bridge J; Sciot R; De Wolf-Peeters C; De Paepe A; Caput D; Speleman F
Br J Cancer; 2000 Feb; 82(4):823-6. PubMed ID: 10732753
[TBL] [Abstract][Full Text] [Related]
6. Acquired expression of transcriptionally active p73 in hepatocellular carcinoma cells.
Sayan AE; Sayan BS; Findikli N; Ozturk M
Oncogene; 2001 Aug; 20(37):5111-7. PubMed ID: 11526499
[TBL] [Abstract][Full Text] [Related]
7. Absence of mutation of the p73 gene localized at chromosome 1p36.3 in hepatocellular carcinoma.
Mihara M; Nimura Y; Ichimiya S; Sakiyama S; Kajikawa S; Adachi W; Amano J; Nakagawara A
Br J Cancer; 1999 Jan; 79(1):164-7. PubMed ID: 10408709
[TBL] [Abstract][Full Text] [Related]
8. Overexpression but lack of mutation and methylation of p73 in hepatocellular carcinoma.
Pan H; Liao SJ; Lai WY; Lu HC; Hsiao KM
Acta Oncol; 2002; 41(6):550-5. PubMed ID: 12546528
[TBL] [Abstract][Full Text] [Related]
9. Mutation, allelotyping, and transcription analyses of the p73 gene in prostatic carcinoma.
Takahashi H; Ichimiya S; Nimura Y; Watanabe M; Furusato M; Wakui S; Yatani R; Aizawa S; Nakagawara A
Cancer Res; 1998 May; 58(10):2076-7. PubMed ID: 9605745
[TBL] [Abstract][Full Text] [Related]
10. Clinical value of alterations in p73 gene, related to p53 at 1p36, in human hepatocellular carcinoma.
Aoki T; Miyamoto A; Marubashi S; Nagano H; Umeshita K; Fujiwara Y; Dono K; Nakamori S; Sakon M; Monden M
Int J Oncol; 2004 Feb; 24(2):441-6. PubMed ID: 14719122
[TBL] [Abstract][Full Text] [Related]
11. Mutation analysis of the p51 gene and correlation between p53, p73, and p51 expressions in prostatic carcinoma.
Takahashi H; Fukutome K; Watanabe M; Furusato M; Shiraishi T; Ito H; Suzuki H; Ikawa S; Hano H
Prostate; 2001 May; 47(2):85-90. PubMed ID: 11340630
[TBL] [Abstract][Full Text] [Related]
12. p73 at chromosome 1p36.3 is lost in advanced stage neuroblastoma but its mutation is infrequent.
Ichimiya S; Nimura Y; Kageyama H; Takada N; Sunahara M; Shishikura T; Nakamura Y; Sakiyama S; Seki N; Ohira M; Kaneko Y; McKeon F; Caput D; Nakagawara A
Oncogene; 1999 Jan; 18(4):1061-6. PubMed ID: 10023682
[TBL] [Abstract][Full Text] [Related]
13. Expression of p73 in colorectal carcinoma: clinicopathological relevance.
Liu L; Cui X; Sakaguchi T; Sasaki M; Suda T; Hatakeyama K
J Int Med Res; 2001; 29(4):297-303. PubMed ID: 11675903
[TBL] [Abstract][Full Text] [Related]
14. Expression of the p53 homologues p63 and p73 in multiple simultaneous gastric cancer.
Tannapfel A; Schmelzer S; Benicke M; Klimpfinger M; Kohlhaw K; Mössner J; Engeland K; Wittekind C
J Pathol; 2001 Sep; 195(2):163-70. PubMed ID: 11592094
[TBL] [Abstract][Full Text] [Related]
15. Transactivation-deficient DeltaTA-p73 acts as an oncogene.
Stiewe T; Zimmermann S; Frilling A; Esche H; Pützer BM
Cancer Res; 2002 Jul; 62(13):3598-602. PubMed ID: 12097259
[TBL] [Abstract][Full Text] [Related]
16. The prognostic value of p73 overexpression in colorectal carcinoma: a clinicopathologic, immunohistochemical, and statistical study of 204 patients.
Toumi AA; El Hadj Oel A; Ben Mahmoud LK; Ben Hmida Ael M; Chaar I; Gharbi L; Mzabi S; Bouraoui S
Appl Immunohistochem Mol Morphol; 2010 Mar; 18(2):128-36. PubMed ID: 19956069
[TBL] [Abstract][Full Text] [Related]
17. The expression of p73 is increased in lung cancer, independent of p53 gene alteration.
Tokuchi Y; Hashimoto T; Kobayashi Y; Hayashi M; Nishida K; Hayashi S; Imai K; Nakachi K; Ishikawa Y; Nakagawa K; Kawakami Y; Tsuchiya E
Br J Cancer; 1999 Jul; 80(10):1623-9. PubMed ID: 10408409
[TBL] [Abstract][Full Text] [Related]
18. Variable expression and absence of mutations in p73 in primary neuroblastoma tumors argues against a role in neuroblastoma development.
Ejeskär K; Sjöberg RM; Kogner P; Martinsson T
Int J Mol Med; 1999 Jun; 3(6):585-9. PubMed ID: 10341287
[TBL] [Abstract][Full Text] [Related]
19. Loss of imprinting and elevated expression of wild-type p73 in human gastric adenocarcinoma.
Kang MJ; Park BJ; Byun DS; Park JI; Kim HJ; Park JH; Chi SG
Clin Cancer Res; 2000 May; 6(5):1767-71. PubMed ID: 10815895
[TBL] [Abstract][Full Text] [Related]
20. Differential expression of p53 family proteins in colorectal adenomas and carcinomas: Prognostic and predictive values.
Bahnassy AA; Zekri AR; Salem SE; Abou-Bakr AA; Sakr MA; Abdel-Samiaa AG; Al-Bradei M
Histol Histopathol; 2014 Feb; 29(2):207-16. PubMed ID: 23996743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]